The site is temporarily down due to maintenance. Sorry for the inconvenience.
The site is temporarily down due to maintenance. Sorry for the inconvenience.
Quality & Accuracy
Experience
The latest technologies
Speed &
Credibility
₾245.00
Macroamylasemia It is a condition in which there is an increase in serum amylase activity without the presence of clinical symptoms of pancreatic diseases. This is due to the association of serum amylase with large molecules (>200 kDa) that cannot be filtered by the kidney, which increases its half-life and serum amylase concentration by 6-8 times.
From a structural point of view, macroamylase is a circulating complex, where amylase is mainly bound to immunoglobulin and rarely to polysaccharide. Immunoglobulins included in the complex are represented by IgA and IgG. The composition of macroamylases is heterogeneous. Pancreatic type (P) and salivary type (S saliva) iso-amylases are obtained by adding macroamylase complexes in an acidic environment.
It is clinically important to distinguish between macroamylasemia and hyperamylasemia associated with other conditions. Unlike acute pancreatitis, macroamylasemia causes prolonged elevation of pancreatic amylase. This is usually the result of reduced enzyme clearance.
Macroamylase may occur in patients with hyperamylasemia and normal urine amylase levels, as well as in humans with normal serum and urine amylase levels.
The table shows the characteristics of different forms of hyperamylasemia:
condition | Serum amylase | serum lipase | urinary amylase | amylase clearance/
Creatinine clearance |
macroamylase |
Pancreatic hyperamylasemia | ↑ | ↑ | ↑ | ↑ | no |
Salivary gland hyperamylasemia | ↑ | norm | ↓ or norm | ↓ or norm | no |
Macroamylasemia type I | ↑ | norm | ↓ | ↓ ↓ | ↑↑ |
Macroamylasemia type II | ↑ | norm | ↓ or norm | ↓ | ↑ |
Macroamylasemia type III | norm | norm | norm | ↓ or norm | trace |
Clinical symptoms are not directly related to macroamylasemia, although it is often found in studies conducted for the cause of abdominal pain.
Often, macroamylasemia is an early sign of the disease, as a specific marker, or may be a non-specific indicator at the beginning of dysproteinemic diseases.
Macroamylasemia is detected in patients with malabsorption syndrome, hepatitis, alcoholic, diabetic, metastatic liver damage, ectopic pregnancy, tubo-ovarian (ovary-appendix) abscesses, and others.
Incidental findings of macroamylasemia may be associated with paraproteinemia caused by myeloma, lymphoma, or acquired immunodeficiency.
Patient preparation – The study is conducted on an empty stomach
Research material - Venous blood
Referral norm – In case of norm, macroamylase is negative in serum.
Testing process
Purchase a test |
Submission of material |
Results Online |
Consult a doctor |
More than 1000 routine and complex/specific diagnostic tests in all major areas of clinical pathology.
53 laboratory centers in 25 cities of Georgia: Tbilisi, Rustavi, Kutaisi, Batumi, Marneuli, Telavi, Zugdidi, Zestafon, Gori, Kobuleti, Akhaltsikhe, Khashuri, Sartichala, Kazbegi, Borjomi, Samtredia, Gurjaani, Lagodekhi, Akhmeta, Ozurgeti, Poti, Chiatura , Kabali village, Dusheti, Kareli, Tianeti.
Use the Synevo web platform to view results from anywhere and anytime
Use the Synevo web platform to view results from anywhere, anytime
From Monday to Saturday you can use the laboratory services at home.
☎️ Hotline: 239 38 33 or 239 40 65
577293008 (9:00-დან 17:00-მდე)
30 laboratory centers in 11 cities of Georgia: Tbilisi, Kutaisi, Batumi, Kobuleti, Zugdidi, Zestaponi, Rustavi, Marneuli, Akhaltsikhe, Telavi, Gori.
More than 3000 routine and complex / specific diagnostic tests in all major areas of clinical pathology.
"Synevo" - Providing a wide range of diagnostic services in Georgia, offering more than 1,000 routine and specific diagnostic tests in all major areas of clinical pathology. By the end of 2024, the Synevo Georgia network will include 3 clinical laboratories and 53 blood sampling units, which will perform more than 300,000 tests.
Contact information
Address: Tsinandali St. N9 (N1 Clinical Hospital area)
2021 – 2024 © Synevo. all rights reserved